BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND CCNE1, CCNE, 898, ENSG00000105173, P24864 AND Prognosis
11 results:

  • 1.
    Cui Y; Jiang Y; Deng X; Long W; Liu B; Fan W; Li Y; Zhang X
    Acad Radiol; 2023 Jul; 30(7):1408-1418. PubMed ID: 36437191
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Machine Learning in Differentiating Gliomas from Primary CNS lymphomas: A Systematic Review, Reporting Quality, and Risk of Bias Assessment.
    Cassinelli Petersen GI; Shatalov J; Verma T; Brim WR; Subramanian H; Brackett A; Bahar RC; Merkaj S; Zeevi T; Staib LH; Cui J; Omuro A; Bronen RA; Malhotra A; Aboian MS
    AJNR Am J Neuroradiol; 2022 Apr; 43(4):526-533. PubMed ID: 35361577
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Role of Radiation Therapy in Younger and Older Adults with Primary Mediastinal Large B Cell lymphoma in Rituximab Era: A U.S. Population-Based Analysis.
    Jiang S; Zhen H; Jiang H
    J Adolesc Young Adult Oncol; 2019 Oct; 8(5):623-627. PubMed ID: 31150309
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis.
    Tian R; Wang J; Yan H; Wu J; Xu Q; Zhan X; Gui Z; Ding M; He J
    Oncogene; 2017 Oct; 36(42):5861-5873. PubMed ID: 28628119
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. LAG-3 Protein Expression in Non-Small Cell Lung Cancer and Its Relationship with PD-1/PD-L1 and Tumor-Infiltrating Lymphocytes.
    He Y; Yu H; Rozeboom L; Rivard CJ; Ellison K; Dziadziuszko R; Suda K; Ren S; Wu C; Hou L; Zhou C; Hirsch FR
    J Thorac Oncol; 2017 May; 12(5):814-823. PubMed ID: 28132868
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.
    Ye Q; Xu-Monette ZY; Tzankov A; Deng L; Wang X; Manyam GC; Visco C; Montes-Moreno S; Zhang L; Dybkær K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Parsons BM; Møller MB; Piris MA; Winter JN; Medeiros LJ; Hu S; Young KH
    Oncotarget; 2016 Jan; 7(3):2401-16. PubMed ID: 26573234
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Estimation of venous thromboembolism risk with thrombotic biomarkers in cancer patients].
    Jianlong M; Diansheng Z; Jing R
    Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):283-9. PubMed ID: 26462893
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prevalence of being underweight and overweight and obesity at diagnosis in UK patients with childhood acute lymphoblastic leukaemia 1985-2002.
    Aldhafiri FK; McColl JH; Reilly JJ
    J Hum Nutr Diet; 2014 Feb; 27(1):76-9. PubMed ID: 23781853
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Clinical significance of serum NGF level and CD271 expression in patients with acute B lymphoid leukemia].
    Han XH; Xu KL; Zeng LY; Li ZY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1273-6. PubMed ID: 22040987
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Diffuse large B-cell lymphoma with overexpression of cyclin e substantiates poor standard treatment response and inferior outcome.
    Tzankov A; Gschwendtner A; Augustin F; Fiegl M; Obermann EC; Dirnhofer S; Went P
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2125-32. PubMed ID: 16609025
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [A tal-1 deletion as real-time quantitative polymerase chain reaction target for detection of minimal residual disease in T-lineage acute lymphoblastic leukemia].
    Wang L; Zhang LP; Li ZG; Cheng YF; Tian KG; Lu AD
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):170-3. PubMed ID: 15833185
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.